JO2324B1 - Pharmaceutical compounds for topical oral use - Google Patents

Pharmaceutical compounds for topical oral use

Info

Publication number
JO2324B1
JO2324B1 JO2000302A JOP20000302A JO2324B1 JO 2324 B1 JO2324 B1 JO 2324B1 JO 2000302 A JO2000302 A JO 2000302A JO P20000302 A JOP20000302 A JO P20000302A JO 2324 B1 JO2324 B1 JO 2324B1
Authority
JO
Jordan
Prior art keywords
fatty acids
oral
esters
compounds selected
topical administration
Prior art date
Application number
JO2000302A
Other languages
Arabic (ar)
English (en)
Inventor
لنريسك ثوماس
ستوكهيل ميلان
فرانل أليس
جيجورف الكسندر
ستوكهيل جوزيف
ماثا فلاديمير
Original Assignee
ايفاكس سي آرايهاس
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO2324(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ايفاكس سي آرايهاس filed Critical ايفاكس سي آرايهاس
Application granted granted Critical
Publication of JO2324B1 publication Critical patent/JO2324B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
JO2000302A 1999-08-17 2000-08-17 Pharmaceutical compounds for topical oral use JO2324B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration

Publications (1)

Publication Number Publication Date
JO2324B1 true JO2324B1 (en) 2005-09-12

Family

ID=10859192

Family Applications (1)

Application Number Title Priority Date Filing Date
JO2000302A JO2324B1 (en) 1999-08-17 2000-08-17 Pharmaceutical compounds for topical oral use

Country Status (40)

Country Link
US (1) US20070190132A1 (cg-RX-API-DMAC7.html)
EP (2) EP1210119B1 (cg-RX-API-DMAC7.html)
JP (2) JP2003507343A (cg-RX-API-DMAC7.html)
KR (2) KR100828747B1 (cg-RX-API-DMAC7.html)
CN (2) CN101406453A (cg-RX-API-DMAC7.html)
AR (2) AR025324A1 (cg-RX-API-DMAC7.html)
AT (2) ATE402691T1 (cg-RX-API-DMAC7.html)
AU (1) AU777740B2 (cg-RX-API-DMAC7.html)
BR (1) BR0013385A (cg-RX-API-DMAC7.html)
CA (2) CA2380951C (cg-RX-API-DMAC7.html)
CO (1) CO5380014A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105318T1 (cg-RX-API-DMAC7.html)
CZ (2) CZ296170B6 (cg-RX-API-DMAC7.html)
DE (2) DE60018081T2 (cg-RX-API-DMAC7.html)
DK (2) DK1334717T3 (cg-RX-API-DMAC7.html)
EE (2) EE04954B1 (cg-RX-API-DMAC7.html)
EG (1) EG23994A (cg-RX-API-DMAC7.html)
ES (2) ES2311077T3 (cg-RX-API-DMAC7.html)
GB (1) GB2355656B (cg-RX-API-DMAC7.html)
HK (1) HK1049629A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20020154B1 (cg-RX-API-DMAC7.html)
HU (1) HUP0203236A3 (cg-RX-API-DMAC7.html)
IL (4) IL148200A0 (cg-RX-API-DMAC7.html)
JO (1) JO2324B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02001631A (cg-RX-API-DMAC7.html)
NO (2) NO20020760L (cg-RX-API-DMAC7.html)
NZ (1) NZ517271A (cg-RX-API-DMAC7.html)
PE (1) PE20010636A1 (cg-RX-API-DMAC7.html)
PL (1) PL192769B1 (cg-RX-API-DMAC7.html)
PT (2) PT1210119E (cg-RX-API-DMAC7.html)
RU (2) RU2279894C2 (cg-RX-API-DMAC7.html)
SA (1) SA00210487B1 (cg-RX-API-DMAC7.html)
SG (1) SG143019A1 (cg-RX-API-DMAC7.html)
SI (1) SI1210119T1 (cg-RX-API-DMAC7.html)
SK (2) SK286083B6 (cg-RX-API-DMAC7.html)
TN (1) TNSN00173A1 (cg-RX-API-DMAC7.html)
UA (2) UA72539C2 (cg-RX-API-DMAC7.html)
UY (1) UY26303A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001012229A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA200308221B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
EP1582206A4 (en) * 2002-12-04 2010-09-22 Nisshin Pharma Inc WATER-SOLUBLE COMPOSITION WITH COENZYM Q10
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムq10を含有する水溶性組成物の製造方法
DK1585548T3 (en) 2002-12-09 2018-09-03 Abraxis Bioscience Llc COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
EP1806125B1 (en) * 2004-10-20 2011-08-03 Kao Corporation Liquid compositions for oral cavity
KR20080003322A (ko) * 2005-02-24 2008-01-07 엘란 파마 인터내셔널 리미티드 도세탁셀 및 이의 유사체의 나노입자 배합물
BRPI0921654A2 (pt) * 2008-11-28 2016-02-10 Advance Holdings Ltd formulação farmacêutica
EP2405892B1 (en) * 2009-03-12 2013-01-16 Advance Holdings Limited Pharmaceutical formulation comprising ketoprofen and a polyoxyalkylene ester of a hydroxy fatty acid
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
EP3274054A1 (en) * 2015-03-27 2018-01-31 Arch Personal Care Products, L.P. Viscosity building composition for personal care products
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用
AU2022360863B2 (en) * 2021-10-08 2025-08-14 Inolex Investment Corporation Biobased polyglyceryl esters and compositions comprising the same
WO2023214509A1 (ja) * 2022-05-02 2023-11-09 中外製薬株式会社 界面活性剤と併用するためのペプチド化合物を含む組成物
CN119770478B (zh) * 2024-12-31 2025-12-19 美济生物医药(广州)有限公司 紫杉醇口服药物组合物、制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ267796A3 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
HU228855B1 (en) * 1997-03-12 2013-06-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
WO1998040051A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
SI0999826T1 (en) * 1997-07-29 2004-12-31 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Also Published As

Publication number Publication date
UY26303A1 (es) 2001-03-16
SG143019A1 (en) 2008-06-27
CA2380951A1 (en) 2001-02-22
NZ517271A (en) 2004-02-27
UA75926C2 (en) 2006-06-15
AR025324A1 (es) 2002-11-20
DK1334717T3 (da) 2008-11-24
RU2279894C2 (ru) 2006-07-20
HK1049629A1 (zh) 2003-05-23
NO20020760D0 (no) 2002-02-15
CA2380951C (en) 2010-03-23
HRP20020154B1 (en) 2006-07-31
WO2001012229A1 (en) 2001-02-22
KR20020059367A (ko) 2002-07-12
IL158108A0 (en) 2004-03-28
KR100828747B1 (ko) 2008-05-09
NO20034778L (no) 2002-04-16
ES2311077T3 (es) 2009-02-01
ATE402691T1 (de) 2008-08-15
PL192769B1 (pl) 2006-12-29
JP2003507343A (ja) 2003-02-25
HRP20020154A2 (en) 2003-12-31
ZA200308221B (en) 2004-09-29
IL158108A (en) 2010-04-15
CZ296591B6 (cs) 2006-04-12
EE200200075A (et) 2003-04-15
JP2004238399A (ja) 2004-08-26
TNSN00173A1 (en) 2005-11-10
EG23994A (en) 2008-03-10
BR0013385A (pt) 2002-05-07
CA2452118A1 (en) 2001-02-22
GB9919288D0 (en) 1999-10-20
DE60322454D1 (de) 2008-09-11
SK2482002A3 (en) 2002-12-03
CO5380014A1 (es) 2004-03-31
PT1210119E (pt) 2005-05-31
AU777740B2 (en) 2004-10-28
PL353445A1 (en) 2003-11-17
EP1334717A3 (en) 2004-01-02
KR20050095651A (ko) 2005-09-29
PT1334717E (pt) 2008-10-09
EP1334717A2 (en) 2003-08-13
UA72539C2 (en) 2005-03-15
MXPA02001631A (es) 2003-07-14
SK286083B6 (sk) 2008-03-05
AU6461300A (en) 2001-03-13
GB2355656B (en) 2004-04-07
HUP0203236A2 (hu) 2003-01-28
IL148200A0 (en) 2002-09-12
NO20034778D0 (no) 2003-10-24
HUP0203236A3 (en) 2004-06-28
EP1210119A1 (en) 2002-06-05
PE20010636A1 (es) 2001-06-02
ATE288766T1 (de) 2005-02-15
DE60018081T2 (de) 2006-01-05
DE60018081D1 (de) 2005-03-17
EE04954B1 (et) 2008-02-15
KR100828748B1 (ko) 2008-05-09
EE200300371A (et) 2003-10-15
CN101406453A (zh) 2009-04-15
DK1210119T3 (da) 2005-06-20
IL148200A (en) 2007-12-03
SI1210119T1 (en) 2005-06-30
EE04955B1 (et) 2008-02-15
ES2237443T3 (es) 2005-08-01
CZ2002575A3 (cs) 2003-05-14
CN1382061A (zh) 2002-11-27
CY1105318T1 (el) 2010-03-03
EP1334717B1 (en) 2008-07-30
RU2279895C2 (ru) 2006-07-20
SA00210487B1 (ar) 2006-09-10
NO20020760L (no) 2002-04-16
CZ296170B6 (cs) 2006-01-11
EP1210119B1 (en) 2005-02-09
AR043106A2 (es) 2005-07-20
RU2003133451A (ru) 2005-04-20
GB2355656A (en) 2001-05-02
US20070190132A1 (en) 2007-08-16
ZA200201315B (en) 2004-06-30

Similar Documents

Publication Publication Date Title
SG143019A1 (en) Pharmaceutical compositions for oral and topical administration
ID26221A (id) Komposisi-komposisi farmasi yang dapat dijadikan gel
ATE279209T1 (de) Injizierbare pharmazeutische zusammensetzung zur systemischen verabreichung pharmakologisch aktiver wirkstoffe enthaltend mittelkettige triglyceride
KR890001521A (ko) 서방형 신규 제약 제제물
UA102477C2 (en) Capsule composition
ATE207346T1 (de) Orale pharmazeutische zusammensetzungen mit sexualhormonen
NO20014719D0 (no) Orale farmasöytiske preparater inneholdende lang-kjedete triglyserider og lipofile overflateaktive midler
UA74339C2 (uk) Форма для введення, що включає інгібітор протонної помпи у вигляді окремих одиниць, та спосіб їх одержання
JPS5525430A (en) Thickening and gelling agent
RU2012120388A (ru) Фармацевтические композиции, включающие производное камптотецина
EP0560322A1 (en) Detergent composition
JP4722351B2 (ja) 酸化的に安定な長鎖エチルエステル皮膚軟化薬
JPS57165305A (en) Method of increasing the potency of bactericidal disinfectant of surface active agent
MY130474A (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
CA2309033A1 (en) Lacrimal gland specific emulsions for topical application to ocular tissue